HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹1896 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 04 Oct 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | 4.08% | 3.23% |
| 6 Month | 3.98% | 8.19% |
| 1 Year | -0.74% | 9.35% |
| 3 Year | 19.26% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | 1.25% | 1.63% |
| 1 Year | 4.32% | 11.09% |
| 3 Year | 18.64% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 18.94% | 27.59% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 15.65% | - |
| Sharp | 0.78% | - |
| Beta | 0.95% | - |
| Alpha | -2.36% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Funds Managed | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 3.56 | 7.7 |
| Large Cap | 29.45 | 26.35 |
| Mid Cap | 37.33 | 30.89 |
| Small Cap | 29.66 | 35.06 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.52 | 1.03 |
| Healthcare | 91.78 | 96.66 |
| Basic Materials | 3.67 | 2.31 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns17.12%
DSP Banking & Financial Services Fund - Reg (G)
3Y Returns0%
Invesco India Dynamic Equity Fund - Growth
3Y Returns13.19%
DSP Dynamic Asset Allocation Fund - Regular Plan - Growth
3Y Returns12.4%
Motilal Oswal Asset Allocation FOF- A- Regular Growth
3Y Returns17.98%
HSBC Income Plus Arbitrage Active FOF - Growth
3Y Returns7.46%
Invesco India Financial Services Fund - Retail Growth
3Y Returns20.93%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns16.9%